Cargando…
Plasma Homocysteine as a Potential Marker of Early Renal Function Decline in IgA Nephropathy
Hyperhomocysteinemia (HHcy) is very common among patients with chronic kidney disease (CKD), and related to the risk of cardiovascular events and mortality in these patients. However, the prevalence of HHcy in primary causes of CKD and its role in kidney disease progression are not well-understood....
Autores principales: | Wang, Yan-Na, Xia, Han, Song, Zhuo-Ran, Zhou, Xu-Jie, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936167/ https://www.ncbi.nlm.nih.gov/pubmed/35321472 http://dx.doi.org/10.3389/fmed.2022.812552 |
Ejemplares similares
-
Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses
por: Zhang, Yue-Miao, et al.
Publicado: (2020) -
Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022) -
HLA-B27 Negativity Is Associated With Renal Function Decline in Patients With Ankylosing Spondylitis and Secondary IgA Nephropathy
por: Zhang, Ti, et al.
Publicado: (2020) -
Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy
por: Li, Zizhen, et al.
Publicado: (2022) -
Prognostic value of chronicity grading on renal outcomes in patients with IgA nephropathy
por: Kang, Donghyuk, et al.
Publicado: (2022)